Studies on preferences for preventive and risk-reducing treatments have been conducted, for example, in individuals at risk of rheumatoid arthritis,26,27 women with the BRCA1/2 gene,28 and individuals at risk of Alzheimer's disease.29 This evidence concerns the gene BRCA1 and rheumatoid arthritis.